DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Dermatomyositis Global Clinical Trials Review, H2, 2016" clinical trials to their offering.
Dermatomyositis Global Clinical Trials Review, H2, 2016
Summary
The author's clinical trial report, Dermatomyositis Global Clinical Trials Review, H2, 2016" provides an overview of Dermatomyositis clinical trials scenario. This report provides top line data relating to the clinical trials on Dermatomyositis.
The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using the author's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Key Topics Covered:
List of Tables & Figures
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Dermatomyositis to Musculoskeletal Disorders Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Dermatomyositis to Musculoskeletal Disorders Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Dermatomyositis Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profile Snapshots
Appendix
Companies Mentioned
- Novartis AG
- AstraZeneca Plc
- Astellas Pharma Inc.
- Truffle Capital
- Octapharma AG
- Amgen Inc.
- Mallinckrodt Plc
- Idera Pharmaceuticals, Inc.
- F. Hoffmann-La Roche Ltd.
For more information about this clinical trials report visit http://www.researchandmarkets.com/research/5zdzbj/dermatomyositis
